Posted January 4, 2017

 

STONY BROOK, N.Y. – Applied DNA Sciences, Inc., a provider of DNA-based supply-chain, anti-counterfeiting and anti-theft technology, product genotyping and product authentication solutions, announced that Dr. Mehmood Khan, PepsiCo's vice chairman and chief scientific officer, Global Research and Development, has joined the company's Strategic Advisory Board (SAB), effective October 2016.

 

Dr. Khan leads PepsiCo's research and development efforts, creating breakthrough innovations in food and beverage product development, delivery, packaging and production technology. He also oversees PepsiCo's global Performance with Purpose agenda, focused on improving health and wellbeing through the products it sells; protecting the planet by reducing the environmental footprint of the company's operations and supply chain; and empowering people and social development around the world.

 

Dr. Khan was recently appointed vice chair of the U.S. Council for Competitiveness and joined the board of Food and Agriculture Research at the USDA (FFAR).

 

"We are thrilled to have Dr. Khan's keen scientific insight and robust commercial experience to help us grow our business in new and growing markets,” said Dr. James Hayward, president and CEO of Applied DNA. “His decades of involvement in the global food, beverage and pharmaceutical industries, as well as his depth of scientific innovation experience, are a perfect complement to Applied DNA as we expand our core vertical markets. With Dr. Khan's appointment to the FFAR, and its engagement with both the National Science Foundation and the U.S. Department of Agriculture, Applied DNA hopes to optimize their benefits to American agronomy and to the world in general. We are honored to have him join our SAB."

 

Dr. Khan said, "Authentication and traceability across complex global supply chains is a critically important priority worldwide. Applied DNA is doing exciting work designed to create innovative solutions that make supply chains more secure. I am honored to join their Strategic Advisory Board and look forward to contributing to their ongoing efforts to protect the integrity of supply chains across industries."

 

Applied DNA Sciences formed its SAB in February 2016 to advance the company's penetration of key market verticals with the assistance of globally recognized experts in their fields. APDN board member Bob Catell, former chairman and CEO of KeySpan and National Grid's U.S. Operations, chairs the SAB. Dr. Khan joins Gunther Faber, former vice president, Sub-Saharan Africa for GlaxoSmithKline, on the SAB.

 

Source: Applied DNA Sciences